279 related articles for article (PubMed ID: 9352586)
1. The olfactory bulbectomized rat as a model of depression: an update.
Kelly JP; Wrynn AS; Leonard BE
Pharmacol Ther; 1997; 74(3):299-316. PubMed ID: 9352586
[TBL] [Abstract][Full Text] [Related]
2. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.
Connor TJ; Harkin A; Kelly JP; Leonard BE
Neuroimmunomodulation; 2000; 7(1):27-35. PubMed ID: 10601816
[TBL] [Abstract][Full Text] [Related]
3. The olfactory bulbectomised rat as a model of depression.
Song C; Leonard BE
Neurosci Biobehav Rev; 2005; 29(4-5):627-47. PubMed ID: 15925697
[TBL] [Abstract][Full Text] [Related]
4. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
5. Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression.
Pistovcakova J; Dostalek M; Sulcova A; Jezova D
Pharmacopsychiatry; 2008 Mar; 41(2):54-9. PubMed ID: 18311685
[TBL] [Abstract][Full Text] [Related]
6. Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?
Cryan JF; McGrath C; Leonard BE; Norman TR
Eur J Pharmacol; 1998 Jul; 352(1):23-8. PubMed ID: 9718263
[TBL] [Abstract][Full Text] [Related]
7. The olfactory bulbectomized rat as a model of depression.
Leonard BE
Pol J Pharmacol Pharm; 1984; 36(5):561-9. PubMed ID: 6099892
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats.
Nowak G; Szewczyk B; Wieronska JM; Branski P; Palucha A; Pilc A; Sadlik K; Piekoszewski W
Brain Res Bull; 2003 Jul; 61(2):159-64. PubMed ID: 12832002
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression.
O'Connor WT; Earley B; Leonard BE
Br J Clin Pharmacol; 1985; 19 Suppl 1():49S-56S. PubMed ID: 2859878
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the antidepressant properties of nitric oxide synthase inhibitors in the olfactory bulbectomised rat model of depression.
Gigliucci V; Gormley S; Gibney S; Rouine J; Kerskens C; Connor TJ; Harkin A
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1349-61. PubMed ID: 24931298
[TBL] [Abstract][Full Text] [Related]
11. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression.
Redmond AM; Kelly JP; Leonard BE
Pharmacol Biochem Behav; 1997 Oct; 58(2):355-9. PubMed ID: 9300592
[TBL] [Abstract][Full Text] [Related]
12. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety.
Wang D; Noda Y; Tsunekawa H; Zhou Y; Miyazaki M; Senzaki K; Nabeshima T
Behav Brain Res; 2007 Mar; 178(2):262-73. PubMed ID: 17261334
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat.
Song C; Leonard BE
Neuroimmunomodulation; 1995; 2(5):263-73. PubMed ID: 8739199
[TBL] [Abstract][Full Text] [Related]
14. Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.
Aswar UM; Kalshetti PP; Shelke SM; Bhosale SH; Bodhankar SL
Asian Pac J Trop Biomed; 2012 Dec; 2(12):992-8. PubMed ID: 23593581
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway.
Pochwat B; Sowa-Kucma M; Kotarska K; Misztak P; Nowak G; Szewczyk B
Psychopharmacology (Berl); 2015 Jan; 232(2):355-67. PubMed ID: 25027582
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Buerger E; Korte M; Ferger B; Olivier B
Eur J Pharmacol; 2009 Aug; 616(1-3):134-40. PubMed ID: 19549514
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
18. An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model.
Iijima M; Chaki S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):622-7. PubMed ID: 17229509
[TBL] [Abstract][Full Text] [Related]
19. The effect of tianeptine and sertraline in three animal models of depression.
Kelly JP; Leonard BE
Neuropharmacology; 1994 Aug; 33(8):1011-6. PubMed ID: 7531300
[TBL] [Abstract][Full Text] [Related]
20. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs.
van Riezen H; Schnieden H; Wren AF
Br J Pharmacol; 1977 Aug; 60(4):521-8. PubMed ID: 907867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
